EUVIMEDEUVIMED entdecken
Crossref

Normal [ 18 F ] FE ‐ PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [ 123 I ] FP ‐ CIT SPECT

Michiel Dhadamus iD, Aline Delva iD, Wies Deckers, Wim Vandenberghe iD, Koen Van Laere

Movement Disorders · 2025

DOI: 10.1002/mds.30255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Michiel Dhadamus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Tomography, Emission-Computed, Single-Photon, Tropanes, Positron-Emission Tomography, Parkinsonian Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In some patients with parkinsonism and abnormal dopamine transporter (DAT) imaging using [ 123 I]FP‐CIT single‐photon emission computed tomography (SPECT), subsequent clinical evolution does not fit well with a neurodegenerative diagnosis.

Objective

The objective was to analyze the results of positron emission tomography (PET) with the recently developed DAT radioligand [ 18 F]FE‐PE2I in patients with persistent diagnostic uncertainty despite an abnormal previous [ 123 I]FP‐CIT SPECT scan.

Methods

This retrospective study included 19 patients with suspected parkinsonism and persistent diagnostic uncertainty after visually abnormal [ 123 I]FP‐CIT SPECT who subsequently underwent [ 18 F]FE‐PE2I PET (time between the two scans: 3.7 ± 2.2 years). Concordance between [ 123 I]FP‐CIT SPECT and [ 18 F]FE‐PE2I PET was determined after either purely visual assessment or semiquantitative analysis.

Results

In 74% of cases with visually abnormal [ 123 I]FP‐CIT SPECT, [ 18 F]FE‐PE2I PET was visually normal. After semiquantitative analysis, 63% of cases with abnormal [ 123 I]FP‐CIT SPECT had normal [ 18 F]FE‐PE2I PET. Conclusions [ 18 F]FE‐PE2I PET is normal in the majority of cases, with persistent diagnostic uncertainty after abnormal [ 123 I]FP‐CIT SPECT. © 2025 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Emission-Computed, Single-PhotonTropanesPositron-Emission TomographyParkinsonian DisordersHumansMaleFemaleAgedMiddle AgedRetrospective StudiesDopamine Plasma Membrane Transport ProteinsUncertaintyRadiopharmaceuticals

Stichwörter der Autor:innen

DAT (dopamine transporter)Parkinson's disease[123I]FP‐CIT[18F]FE‐PE2Iparkinsonism

Substanzen

Tropanes2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneDopamine Plasma Membrane Transport ProteinsRadiopharmaceuticals

Autor:innen und Institutionen

  • Division of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
  • Laboratory for Parkinson Research, Department of Neurosciences, KU Leuven, Leuven, Belgium.
  • Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.

ORCID-Profile: Michiel Dhadamus, Aline Delva, Wim Vandenberghe

Zitieren

APA

Dhadamus, M., Delva, A., Deckers, W., Vandenberghe, W., & Van Laere, K. (2025). Normal [ 18 F ] FE ‐ PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [ 123 I ] FP ‐ CIT SPECT. Movement Disorders. https://doi.org/10.1002/mds.30255

Vancouver

Dhadamus M, Delva A, Deckers W, Vandenberghe W, Van Laere K. Normal [ 18 F ] FE ‐ PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [ 123 I ] FP ‐ CIT SPECT. Movement Disorders. 2025. doi:10.1002/mds.30255

BibTeX
@article{Dhadamus2025,
  author = {Dhadamus, Michiel and Delva, Aline and Deckers, Wies and Vandenberghe, Wim and Van Laere, Koen},
  title = {Normal [ 18 F ] FE ‐ PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [ 123 I ] FP ‐ CIT SPECT},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30255}
}
Kostenlos starten →